Current Status of BTKi Treatment for CLL/SLL in China — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Current Status of BTKi Treatment for CLL/SLL in China — Stella

View on ClinicalTrials.gov

Recruiting

Back to CLL/SLL trials

Trial locations(1 site)

China

Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjin, Jiangsu

Key details

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Enrollment target

~1,000 participants

Started

July 2024

Primary completion

February 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.